Elamipretide SS-31 CAS 736992-21-5 Synthetic Peptide Research Raw Material, Factory Supply for In Vitro Laboratory Research

Product Overview SS-31 (Elamipretide, CAS 736992-21-5) is a synthetic tetrapeptide belonging to the Szeto-Schiller peptide family. Its peptide sequence: D-Arg-Dmt-Lys-Phe-NH₂. Dmt refers to 2,6-dimethyl-L-tyrosine. It is produced via mature solid-phase peptide synthesis (SPPS) route, followed by purification, lyophilization and strict batch inspection. The product appears as white to off-white lyophilized powder.

This product is classified as research raw material, not finished drug. It is suitable for university laboratories, biotechnology research institutions and formulation research laboratories, used for basic bioscience research, peptide property characterization, in-vitro cell related experiments and biochemical pathway exploration. All experiments using this raw material must be operated inside laboratory environment. Any application related to human body is strictly prohibited. Buyers shall fully understand the usage limitation and bear full responsibility for all operations of this material.

Application Scope (Research Only) This raw material is used for laboratory basic research, peptide structural property study, mitochondrial related biological exploration, cell model in-vitro tests, biochemical interaction research and other scientific projects. It can only be applied for in-vitro laboratory tests. It cannot be used for clinical trials, human consumption or animal disease intervention.

Packaging & Shipping Available package options: 5mg,10mg,20mg,50mg,100mg,500mg,1g. Customized packaging is acceptable according to customer requirements. We use sealed vial packing to protect product stability during transportation. Goods are properly packed to avoid damage, moisture and contamination in transit.

Sample service is available for customer quality evaluation before bulk purchase. Lead time can be confirmed based on order quantity. We adopt professional packaging solution which meets international logistics requirements.

Important Disclaimer This product is for laboratory scientific research only. It is NOT a pharmaceutical finished product. It shall not be used for any human-related application. The seller does not authorize any medical usage of this product. All users must comply with local laws and regulations when storing, handling and using this research raw material. The buyer shall assume all liabilities arising from improper use of this product.

1. Mature synthesis process: Produced by solid-phase peptide synthesis technology, strict purification and lyophilization process, stable peptide property and batch consistency.
2. Complete QC & traceability: Each batch undergoes HPLC and MS identification, COA available. HPLC spectrum and MS documents can be supplied on request. Batch sample retention for traceability.
3. Flexible packaging & sample support: Multiple standard vial specifications available, custom packaging acceptable. Samples can be supplied for lab test and quality verification.
4. Factory direct supply: Stable production capacity, flexible lead time, support small trial sample orders and large bulk orders. Suitable international transportation packaging.
5. Clear usage boundary: This is research-only raw material, not finished medicine. Not for human use. Full disclaimer clarifies application scope for buyers.

What is SS-31?
Elamipretide (SS-31) is a small peptide that can reach inside the mitochondria and affect mitochondrial function maintenance. Elamipretide belongs to a family of cell-penetrating peptides that target and accumulate at the inner mitochondrial membrane. Inside the mitochondria, elamipretide binds to cardiolipin, an essential component of the inner mitochondrial membrane, and restores the mitochondria.

Given the effects of elamipretide on mitochondrial function and maintenance, treatment with elamipretide is under investigation to determine its benefits on human health. Recently, scientists have discovered at least four excellent benefits that can potentially make elamipretide a viable treatment option for a wide variety of conditions.

In diabetes research, SS-31 can improve mitochondrial dysfunction related to diabetes and has potential value in the treatment of diabetes and its complications. For sepsis, SS-31 can reduce vascular permeability in septic rats. The protective effect is related to the inhibition of oxidative stress, providing a new strategy for clinical treatment.